University Medical Centre Mannheim

Institution (Funder)

Homepage ROR

Also Known As

University Medical Centre Mannheim, Universitätsklinikum Mannheim · Acronym: UMM

20.7K

Publications

1.7M

Citations

979

Authors

1.7K

Concepts

About

University Medical Centre Mannheim is a funder institution in Mannheim, Germany known for medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	92	2.1K	114.5K
2	Engineering	65	916	49.9K
3	Education	14	41	2.4K
4	Arts	6	11	282
5	Business	4	4	201

University Medical Centre Mannheim

20.7K

Publications

1.7M

Citations

Page 1

	Year	Citations
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 Marie Ng, Tom Fleming, Margaret S. Robinson, The Lancet ObesityGlobal BurdenChildhood ObesityGlobal HealthObesity Management	2014	11.9K
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines Peter J. Murray, Judith E. Allen, Subhra K. Biswas, Immunity Macrophage BiologyInflammationCytokineSignal TransductionMacrophage Activation	2014	6K
Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue Susanne Kern, Hermann Eichler, Johannes Stoeve, Stem Cells Tissue EngineeringAdult Stem CellBiomedical EngineeringRegenerative MedicineBone Marrow	2006	3.3K
DNA methylation-based classification of central nervous system tumours David Capper, David Jones, Martin Sill, Nature Neuro-oncologyDna Methylation-based ClassificationMedicineEpigenetic ChangeDna Methylation	2018	2.9K
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells Frank O. Nestlé, Selma Alijagic, Michel Gilliet, Nature Medicine VaccinationTumor ImmunologyCancer ImmunosurveillanceMelanomaImmunology	1998	2.9K
A classification of chronic pain for ICD-11 Rolf‐Detlef Treede, Winfried Rief, Antonia Barke, Pain	2015	2.6K
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial Salah‐Eddin Al‐Batran, Nils Homann, Claudia Pauligk, The Lancet Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicineVersus Fluorouracil	2019	2.4K
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Blood	2022	2.4K
Hydrocortisone Therapy for Patients with Septic Shock Charles L. Sprung, Djillali Annane, Didier Keh, New England Journal of Medicine	2008	2.1K
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla, The Lancet Metastatic Soft-tissue SarcomaPlacebo-controlled Phase 3MedicineMetronomic TherapyClinical Trials	2012	2K

Page 1